Healthcare Costs of Potential Glucocorticoid-Associated Adverse Events in Patients with Giant Cell Arteritis.

Best, Jennie H; Kong, Amanda M; Smith, David M; Abbass, Ibrahim; Michalska, Margaret

Best, Jennie H; Kong, Amanda M; Smith, David M; Abbass, Ibrahim; Michalska, Margaret.

Afiliación

Best JH; Genentech, Inc., South San Francisco, CA, USA.
Kong AM; IBM Watson Health, Cambridge, MA, USA.
Smith DM; IBM Watson Health, Cambridge, MA, USA.
Abbass I; Genentech, Inc., South San Francisco, CA, USA.
Michalska M; Genentech, Inc., South San Francisco, CA, USA.

Clinicoecon Outcomes Res ; 11: 799-807, 2019.

Article en En | MEDLINE | ID: mdl-31920351

Palabras clave

adverse events; giant cell arteritis; glucocorticoid; healthcare expenditures

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clinicoecon Outcomes Res Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google